Navigation Links
Pediatric cancer charities partner to fund international collaborative research
Date:3/4/2013

Solving Kids' Cancer, along with U.K.-based charities Neuroblastoma Alliance UK, J-A-C-K, and other European organizations have aligned forces to improve access to promising clinical trials for children with high-risk neuroblastoma in North America, the U.K. and Europe. The aim of the International Neuroblastoma Research Collaborative (INBRC) is to bring the cancer research community together to produce immunotherapy options to treat, control and prevent the recurrence of neuroblastoma in children. The new initiative mandates a collaboration of international cancer centers, offering a grant award of up to $500,000 (USD).

The pediatric cancer charities have partnered for the first time to create new treatments for children with neuroblastoma who at best, have a 5 percent chance of survival after relapse.

Neuroblastoma is a cancer of the sympathetic nervous system that most commonly occurs in infants and children under 5 years old. The cancer is usually discovered after it has spread. Half of all children are diagnosed with high-risk neuroblastoma, which is one of the most aggressively treated of all cancers. Standard treatments include months of chemotherapy, surgery, radiation, and stem cell transplant, followed by additional months of maintenance therapy.

"Even after such intense treatment, about 60 percent of children relapse within three years," said Scott Kennedy, the Executive Director of Solving Kids' Cancer. "Immunotherapy can offer these children less toxic and more effective treatments, and offers more potential of curing relapsed neuroblastoma than chemotherapy and radiation."

Immunotherapy for cancer has rapidly advanced in recent years and shown success in some adult cancers, but few options are available for children, especially in Europe.

"This collaboration is significant, not only because of the amount of funding but also because we are creating more access to clinical trials for children," said Richard Brown, Chair at J-A-C-K. "Alliances can bring new ideas; focus new energies; and produce new action to defeat a cancer that preys upon the youngest. By bringing together both the advocacy community and the scientific community to work across continents, we can only maximize the hope that options such as immunotherapy may offer to children affected by neuroblastoma."

Neuroblastoma Alliance UK's Chief Executive, Alison Moy, agreed, "We are really excited to be involved in this collaboration, which is taking parent advocacy and the involvement of charities in furthering research to a new level. As neuroblastoma only affects children, it is not considered a common cancer and therefore research funding has been limited. We believe that children should be able to access the best possible treatment, wherever that may be and that's why we support families to access clinical treatment abroad. We hope that through the INBRC project, more children from the U.K. will be able get effective treatment, wherever that trial is taking place."


'/>"/>

Contact: Jenny Song
jenny@solvingkidscancer.org
212-588-6625
Solving Kids' Cancer
Source:Eurekalert

Related medicine news :

1. Study identifies growth factor essential to the most common malignant pediatric brain tumor
2. Pediatricians Say No to Expulsions, Suspensions at Schools
3. Pediatrics Group Issues New Ear Infection Guidelines
4. Bhatia honored by Southern Society for Pediatric Research
5. Tube versus IV feeding in malnourished pediatric cancer patients
6. Lancet Oncology: Long-term side-effects of targeted therapies in pediatric cancer patients
7. Pediatric orthopaedic surgeons show age-related patterns of spine injury in ATV injuries
8. Westminster Pediatrician Residents Love Encourages Flu Shots for the Whole Family at Indian Crest Pediatrics
9. Dont Cut School Recess, Pediatricians Say
10. Study reports racial disparities in pediatric appendicitis treatment tied to hospital type
11. Ben-Gurion U and Cincinnati Childrens Hospital to develop new pediatric medical devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology: